 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
 |
 |
 |
|
|
About SCOP
|
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
| The International Transplant Skin Cancer Collaborative is our sister organization in North-America and Australia. | |
| The SCOP Network Aftercare in organ grafted patients still focuses on prevention and therapy of organ rejection. Facing increasing survival times of grafted patients, nowadays regular dermatological checkups become more and more important. While in the first year following transplantation special emphasis is given to the prevention of viral, bacterial and fungal infections, a significant increased incidence of non-melanoma skin cancer is paralleling the extended survival rates of grafted patients. Cancer is now responsible for a mortality rate of 5-8%. With almost 50% of all malignancies in transplant patients, non-melanoma skin cancer, especially squamous cell carcinomas (SCC) and their precursors actinic keratoses (AK), represents the majority of neoplasm diagnosed in this special group of patients. The SCOP Network is designed as an interdisciplinary Network of dermatologists, transplant physicians, patient support groups and basic researchers to match the increasing needs of qualified dermatological aftercare in this fascinating field of modern medicine. The SCOP Network meanwhile exists since December 2000 on national levels (France, Italy, Germany) and was expanded onto a European Level in June 2002. Internationally close cooperation with the North-American and Australian ITSCC (International Skin Cancer in Organ Transplant Patients Collaborative Group) represent a integral element and stress the need for a global collaboration in the field of transplant dermatology. Using a internet-based data registry uniting multiple specialized dermatological outpatient-departments allover Europe it allows collecting comprehensive amounts of epidemiological data on skin diseases in organ transplants. Various risk-factors as different immunosuppressive regimens, exposition of ultraviolet radiation, oncogenous viruses just to give a few examples are compared with regard to their specific role in this setting. Furthermore the data gathered is used to reevaluate existing strategies of skin cancer prevention as well as to develop new therapeutic options for cancerous and infective skin diseases – not only in the setting of systemic immunosuppression - likewise. On the following pages we offer an overview on our current working process, information for patients, colleagues and researchers likewise. Though this pages contains medical information it is in no ways the interest of this page to substitute the qualified dermatolgical aftercare provided through your local dermatologists and involved transplant physicians. Furthermore we can not an will in no ways provide personal medical advice over the internet but have to refer you to you local specialist or your nearest SCOP-center. Thanks for your interest. Claas Ulrich Secretary European SCOP Network Webmaster |
|
|
17.03.2003
|
||
|
||
|
16.10.2003
|
||
|
||
|
24.09.2003
|
||
|
||
|
27.11.2003
|
||
|
||
|
Credits
|
|
| Concept Claas Ulrich, MD Dirk Wippermueller Graphics & Layout Duc Van Dang Coding & Database Dirk Wippermueller |
|
|
Copyright Note - All content of this website is property of SCOP Network ( T ). Any further use or distribution of this site's content or parts of this site requires written permission of SCOP Network ( T ).
|
|||